A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck
Seiwert, T.Y., Fayette, J., Cupissol, D., del Campo, J.M., Clement, P.M., Hitt, R., Degardin, M., Zhang, W., Blackman, A., Ehrnrooth, E., Cohen, E.E.W.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer
Vergote, I, du Bois, A, Floquet, A, Rau, J, Kim, J.-W, del Campo, J.M, Friedlander, M, Pignata, S, Fujiwara, K, Colombo, N, Mirza, M.R, Monk, B.J, Tsibulak, I, Calvert, P.M, Herzog, T.J, Hanker, L.C, Meunier, J, Lee, J.-Y, Bologna, A, Carrasco-Alfonso, M.J, Harter, P
Published in Gynecologic oncology (01.11.2019)
Published in Gynecologic oncology (01.11.2019)
Get full text
Journal Article
Tumor Biomarker Association With Clinical Outcomes in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Patients (Pts) Treated With Afatinib Versus Methotrexate (MTX): LUX-Head & Neck 1 (LHN1)
Cohen, E, Licitra, L, Burtness, B, Fayette, J, Gauler, T, Clement, P.M, Grau, J.J, del Campo, J.M, Mailliez, A, Haddad, R.I, Vermorken, J.B, Tahara, M, Guigay, J, Geoffrois, L, Merlano, M.C, Cong, X.J, Gibson, N, Solca, F, Ehrnrooth, E, Machiels, J.P.H
Published in International journal of radiation oncology, biology, physics (15.03.2016)
Published in International journal of radiation oncology, biology, physics (15.03.2016)
Get full text
Journal Article
OC-005: Afatinib versus methotrexate in recurrent/metastatic HNSCC after platinum therapy: LUX-head and neck
Clement, P, Gauler, T, Machiels, J.P.H, Haddad, R, Fayette, J, Licitra, L.F, Tahara, M, Vermorken, J.B, Cupissol, D, Grau, J.J, Guigay, J, Caponigro, F, de Castro, G, de Souza Viana, L, Keilholz, U, del Campo, J.M, Cong, X.J, Svensson, L, hrnrooth, E, Cohen, E.E.W
Published in Radiotherapy and oncology (01.02.2015)
Published in Radiotherapy and oncology (01.02.2015)
Get full text
Journal Article
Clinical surrogate markers of survival in advanced non-small cell lung cancer (NSCLC) patients treated with second–third line erlotinib
Cedrés, Susana, Prat, Aleix, Martínez, Pablo, Pallisa, Esther, Sala, Gemma, Andreu, Jordi, del Campo, J.M, Quispe, Isela, Baselga, José, Felip, Enriqueta
Published in Lung cancer (Amsterdam, Netherlands) (01.11.2009)
Published in Lung cancer (Amsterdam, Netherlands) (01.11.2009)
Get full text
Journal Article
Feasibility of a modified outpatient regimen of intravenous/intraperitoneal chemotherapy in optimally debulked stage III ovarian cancer patients: a GEICO study
Oaknin, Ana, Roda, Desamparado, González-Martín, Antonio, Chiva, Luis, García-Donas, Jesús, de Juan, Ana, Redondo, Andrés, Martínez, Sergio, García, Yolanda, Catot, Sílvia, Ponce, Jordi, Del Campo, J M, Cervantes, Andrés, Poveda, Andrés
Published in International journal of gynecological cancer (01.08.2011)
Published in International journal of gynecological cancer (01.08.2011)
Get full text
Journal Article
8004 ORAL Safety and Efficacy Outcomes in Heavily and Non-heavily Pretreated Patients With Recurrent Ovarian Cancer (ROC) After Single-agent Trabectedin Treatment – Pooled Analysis of Phase II Trials
Colombo, N, Del Campo, J.M, Sehouli, J, Sessa, C, Bidzinski, M, Nieto, A, Jiao, J, Kurzedei^, C, Boman, K, Gonzalez-Martin, A
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
1255 POSTER Outcomes in Patients 70 Years and Older Enrolled in Phase I Studies at Vail D'Hebron University Hospital
Barrera, R. Morales, Castillo-Fernandez, O, Brafia, I, Dienstmann, R, Cortes, J, Felip, E, Del Campo, J.M, Carles, J, Rodon, J, Tabernero, J
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
8047 Feasibility of a modified outpatient regimen of intravenous/intraperitoneal chemotherapy (IV/IP) in optimally debulked stage III ovarian cancer patients: A GEICO Study
Oaknin, A, Roda, D, Gonzalez-Martin, A, García-Donas, J, deJuan, A, Redondo, A, Catot, S, del Campo, J.M, Perez, X, Poveda, A
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer
Cohen, E.E.W., Licitra, L.F., Burtness, B., Fayette, J., Gauler, T., Clement, P.M., Grau, J.J., del Campo, J.M., Mailliez, A., Haddad, R.I., Vermorken, J.B., Tahara, M., Guigay, J., Geoffrois, L., Merlano, M.C., Dupuis, N., Krämer, N., Cong, X.J., Gibson, N., Solca, F., Ehrnrooth, E., Machiels, J.-P.H.
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article
Phase II randomized study of PM01183 versus topotecan in patients with platinum-resistant/refractory advanced ovarian cancer
Poveda, A., del Campo, J.M., Ray-Coquard, I., Alexandre, J., Provansal, M., Guerra Alía, E.M., Casado, A., Gonzalez-Martin, A., Fernández, C., Rodriguez, I., Soto, A., Kahatt, C., Fernández Teruel, C., Galmarini, C.M., Pérez de la Haza, A., Bohan, P., Berton-Rigaud, D.
Published in Annals of oncology (01.06.2017)
Published in Annals of oncology (01.06.2017)
Get full text
Journal Article
5034 POSTER Pharmacokinetics of trabectedin in women with recurrent ovarian cancer
del Campo, J.M, Pardo, B, Cervantes, A, Gonzalez, A, Parera, A, Cuadra, C, Lebedinsky, C, Miguel-Lillo, B, Soto-Matos, A, Izquierdo, M.A
Published in European journal of cancer supplements (2007)
Published in European journal of cancer supplements (2007)
Get full text
Journal Article
Intentional poisonings: Report from the Catholic University Poison Information Center 2006–2015
Reinike, C., Silva, L., Cerda, P., Mieres, J.J., Del Campo, J.M., Paris, E., Ríos, J.C.
Published in Toxicology letters (10.10.2016)
Published in Toxicology letters (10.10.2016)
Get full text
Journal Article
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial
Clement, P.M., Gauler, T., Machiels, J.P., Haddad, R.I., Fayette, J., Licitra, L.F., Tahara, M., Cohen, E.E.W., Cupissol, D., Grau, J.J., Guigay, J., Caponigro, F., de Castro, G., de Souza Viana, L., Keilholz, U., del Campo, J.M., Cong, X.J., Ehrnrooth, E., Vermorken, J.B.
Published in Annals of oncology (01.08.2016)
Published in Annals of oncology (01.08.2016)
Get full text
Journal Article
Quality of life in patients with recurrent ovarian cancer (OC) treated with niraparib: Results from the ENGOT-OV16/NOVA Trial
Oza, A.M., Matulonis, U.A., Malander, S., Sehouli, J., del Campo, J.M., Berthon-Rigaud, D., Banerjee, S., Scambia, G., Berek, J.S., Lund, B., Tinker, A.V., Hilpert, F., Palacio Vázquez, I., D’Hondt, V., Benigno, B., Provencher, D.M., Buscema, J., Hudgens, S., Agarwal, S., Mirza, M.R.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer
Del Campo, J. M., Roszak, A., Bidzinski, M., Ciuleanu, T. E., Hogberg, T., Wojtukiewicz, M. Z., Poveda, A., Boman, K., Westermann, A. M., Lebedinsky, C.
Published in Annals of oncology (01.11.2009)
Published in Annals of oncology (01.11.2009)
Get full text
Journal Article
889PPHASE I DOSE-ESCALATION STUDY TO DETERMINE THE MAXIMUM TOLERATED DOSE (MTD) OF NINTEDANIB (BIBF 1120) IN COMBINATION WITH CARBOPLATIN/PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) IN PATIENTS (PTS) WITH RECURRENT OVARIAN CANCER (ROC)
Del Campo, J.M., Pardo Búrdalo, B., Rodriguez Freixinos, V., Gaba Garcia, L., Gil Martín, M., Oaknin, A., Ballester, A., Sailer, M.O., Merger, M., Morsli, N., Vidal, L.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Phase I Dose-Escalation Study to Determine the Maximum Tolerated Dose (Mtd) of Nintedanib (Bibf 1120) in Combination with Carboplatin/Pegylated Liposomal Doxorubicin (Pld) in Patients (Pts) with Recurrent Ovarian Cancer (Roc)
Del Campo, J.M., Pardo Búrdalo, B., Rodriguez Freixinos, V., Gaba Garcia, L., Gil Martín, M., Oaknin, A., Ballester, A., Sailer, M.O., Merger, M., Morsli, N., Vidal, L.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
314O_PR Second-line afatinib vs methotrexate (MTX) in patients (pts) with recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC): subgroup/biomarker analysis of LUX-head and neck 1 (LUX-H&N1)
Tahara, M., Cohen, E.E.W., Haddad, R.I., Fayette, J., Licitra, L.F., Clement, P.M., Vermorken, J.B., Gauler, T., Cupissol, D., Grau, J.J., Guigay, J., del Campo, J.M., Okami, K., Takahashi, S., Burtness, B., Cong, X.J., Gibson, N., Solca, F., Ehrnrooth, E., Machiels, J.-P.H.
Published in Annals of oncology (01.12.2015)
Published in Annals of oncology (01.12.2015)
Get full text
Journal Article